FDA | Life Science News | NIH | U.S. Congress
Federal Judge ruled missing clinical trial data must be made public
On Feb. 22, 2020, a federal judge from the Southern District of New York ruled drug companies, device…
FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
The FDA approved non-statin drug to treat high cholesterol
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…
University of Missouri alumni gave $2 million gift to NextGen Precision Health Institute
On Feb. 21, 2020, a $2 million gift from University of Missouri alumni will support the university’s NextGen…
FDA authorized marketing of first genetic test to aid in diagnosis of Fragile X Syndrome
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
COVID-19 coronavirus spike holds infectivity details
On Feb. 24, 2020, researchers reported that the spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia…
Artificial Intelligence | Biotechnology | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Tim and Mary Boyle gave $10 million to OHSU for joint center for biomedical data science
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Therapeutics | Vaccine
The CPRIT awarded 55 new grants totaling over $78 million
On Feb. 19, 2020, Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55 grants…
Sanofi joined with U.S. Dept of Health and Human Services to advance novel coronavirus vaccine
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…
COVID-19 | Life Science News | NIH | Vaccine
Medigen Vaccine Biologics and NIH collaborated to develop COVID-19 vaccine
On Feb. 16, 2020, Medigen Vaccine Biologics (MVB) and the National Institutes of Health (NIH) announced they had…
New, detailed molecular roadmap boosted fight against endometrial cancer
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
Remdesivir prevented MERS coronavirus disease in monkeys
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
Vir Biotec identified two antibodies that bind to spike protein of SARS-CoV-2
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
WHO and FIND formalized strategic collaboration to drive universal access to essential diagnostics
On Feb. 10, 2020, the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) announced…
The Pan-cancer analysis of whole genomes was published in Nature
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
$675 million needed for new coronavirus preparedness and response global plan
On Feb. 5, 2020, to fight further spread of the new coronavirus (2019-nCoV) outbreak in China and globally,…
International collaboration generated most complete cancer genome map to date
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
BioMotiv and Bristol-Myers Squibb announced the Launch of Anteros Pharmaceuticals
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
Fred Hutch trial halted after promising HIV vaccine failed to show efficacy
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
Vaxart announced initiation of Coronavirus vaccine program
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based…
Taconic Biosciences Launched new immuno-oncology mouse model
On Jan 31, 2020, Taconic Biosciences announced that it had expanded its immuno-oncology portfolio with the launch of…
U.S. Department of Health and Human Services announced COVID-19 Public Health Emergency
On Jan. 31, 2020, the U.S. Departments of Health and Human Services announced that as a result of…
WHO declared coronavirus outbreak a global health emergency
On Jan. 30, 2020, The WHO announced that the outbreak of a deadly and fast-spreading strain of coronavirus…
The CDC confirmed person-to-person spread of new coronavirus in the U.S.
On Jan. 30, 2020, the Centers for Disease Control and Prevention (CDC) confirmed that the 2019 Novel Coronavirus…
Artificial Intelligence | Biotechnology | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Therapeutics
New center to fund ‘most exciting’ biomedical discoveries
On Jan. 30, 2020, the University of Washington (UW) announced that a new center was being created with…
23andMe signed a strategic agreement with Almirall
On Jan. 29, 2020, 23andMe announced an agreement with Almirall to in-license 23andMe’s bispecific monoclonal antibody designed to…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Therapeutics | Vaccine | Women's Health
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
WHO, China leaders discuss next steps in battle against coronavirus outbreak
On Jan. 28, 2020, the Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, met President…
AbCellera mobilized response to the novel coronavirus outbreak as part of its DARPA P3 program
On Jan. 28, 2020, AbCellera confirmed that it had mobilized its pandemic response platform against the ongoing outbreak…